IDEXX Laboratories, Inc. (IDXX) News

IDEXX Laboratories, Inc. (IDXX): $678.53

-25.63 (-3.64%)

POWR Rating

Component Grades













Filter IDXX News Items

IDXX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

IDXX News Highlights

  • 500 - Internal server error
  • Over the past 29 days, IDXX's stories per day has been in a clear downtrend, falling by about 0.46 per day.
  • The most mentioned tickers in articles about IDXX are HCA, CAG and ESP.

Latest IDXX News From Around the Web

Below are the latest news stories about Idexx Laboratories Inc that investors may wish to consider to help them evaluate IDXX as an investment opportunity.

Why IDEXX Laboratories (IDXX) Might Surprise This Earnings Season

IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | July 29, 2021

Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?

Style Box ETF report for JPME

Yahoo | July 28, 2021

Robust Valuation Leaves Neogen Little Room For Error After Mixed Results

dusanpetkovic/iStock via Getty Images Neogen (NEOG) has never traded in line with normal valuation metrics, and it may well never do so – or at least not over a reasonable investment horizon. The reality is that there’s scarcity value in the growth markets of food safety and animal safety, and...

Stephen Simpson on Seeking Alpha | July 27, 2021

What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?

IDEXX's (IDXX) fiscal second-quarter top line is expected to have benefited from strength in CAG and LPD businesses.

Yahoo | July 27, 2021

IDEXX Laboratories: This Growth Name Is On Fire

Marko Geber/DigitalVision via Getty ImagesFast-growers with industry-leading positions have a place in most portfolios. These may be the type of investments that one can set in a portfolio and leave there for many years, until they need to be cashed out. In this article, I’m focused on IDEXX Laboratories (IDXX),...

Gen Alpha on Seeking Alpha | July 25, 2021

Animal Health Diagnostics Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: IDEXX Laboratories (US), Abaxis (US), Thermo Fisher Scientific (US), Neogen (US),

The documented report on Global Animal Health Diagnostics Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or []

Jumbo News | July 25, 2021

Animal Health Diagnostics Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:IDEXX Laboratories (US), Abaxis (US), Thermo Fisher Scientific (US), Neogen (US), Hesk

This report studies the Animal Health Diagnostics Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Animal Health Diagnostics market segmented by company, []

Jumbo News | July 24, 2021

Global Food Additives Testing Market 2021 With Pre & Post COVID-19 Impact Analysis | Top Key Players | Bureau Veritas Sa, IFP Institut Für Produktqualit t Gmbh, Idexx Laboratories Inc, Aegis Food Testing Laboratories Inc

Market Research Store has released its latest study on the Food Additives Testing Market, which calculates market growth trends using historical data and assesses future prospects based on thorough research. The Food Additives Testing analysis covers market segmentation, growth, trends, and forecasting for the years 2021-2026. Every minute detail of the Food Additives Testing Market is []

Jumbo News | July 23, 2021

Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 23, 2021

3 Surprising Stocks That Have Crushed the Market so Far This Year

Shares of HCA Healthcare (NYSE: HCA) have skyrocketed more than 50% so far in 2021. HCA CEO Sam Hazen said in the company's recent second-quarter earnings call that HCA "experienced a strong rebound in demand for our services," thanks to a lower impact from the pandemic. Hazen noted that COVID-19 admissions in Q2 were only 3% of HCA's total admissions, compared to 10% in Q1.

Yahoo | July 22, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.814 seconds.